(2026). A first in disease trial of the safety, tolerability, and anti‐seizure effects of ES‐481 in drug‐resistant epilepsy. Epilepsia Open.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"A First in Disease Trial of the Safety, Tolerability, and Anti‐seizure Effects of ES‐481 in Drug‐resistant Epilepsy."
Epilepsia Open 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"A First in Disease Trial of the Safety, Tolerability, and Anti‐seizure Effects of ES‐481 in Drug‐resistant Epilepsy."
Epilepsia Open, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.